IL105527A0 - 17-beta-acyl-aromatic steroid 5-alpha-reductase inhibitors - Google Patents

17-beta-acyl-aromatic steroid 5-alpha-reductase inhibitors

Info

Publication number
IL105527A0
IL105527A0 IL105527A IL10552793A IL105527A0 IL 105527 A0 IL105527 A0 IL 105527A0 IL 105527 A IL105527 A IL 105527A IL 10552793 A IL10552793 A IL 10552793A IL 105527 A0 IL105527 A0 IL 105527A0
Authority
IL
Israel
Prior art keywords
acyl
beta
alpha
reductase inhibitors
aromatic steroid
Prior art date
Application number
IL105527A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209408A external-priority patent/GB9209408D0/en
Priority claimed from GB929224210A external-priority patent/GB9224210D0/en
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL105527A0 publication Critical patent/IL105527A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0014Androstane derivatives substituted in position 17 alfa, not substituted in position 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL105527A 1992-04-30 1993-04-27 17-beta-acyl-aromatic steroid 5-alpha-reductase inhibitors IL105527A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209408A GB9209408D0 (en) 1992-04-30 1992-04-30 Compounds
GB929224210A GB9224210D0 (en) 1992-11-18 1992-11-18 Compounds

Publications (1)

Publication Number Publication Date
IL105527A0 true IL105527A0 (en) 1993-08-18

Family

ID=26300800

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105527A IL105527A0 (en) 1992-04-30 1993-04-27 17-beta-acyl-aromatic steroid 5-alpha-reductase inhibitors

Country Status (21)

Country Link
US (1) US5618806A (fi)
EP (1) EP0638090A4 (fi)
JP (1) JPH07506363A (fi)
KR (1) KR950701340A (fi)
CN (1) CN1095071A (fi)
AU (1) AU4291993A (fi)
BG (1) BG99145A (fi)
BR (1) BR9306419A (fi)
CA (1) CA2134231A1 (fi)
CZ (1) CZ266694A3 (fi)
FI (1) FI945105A0 (fi)
HU (1) HUT72467A (fi)
IL (1) IL105527A0 (fi)
MA (1) MA22886A1 (fi)
NO (1) NO944124L (fi)
NZ (1) NZ252866A (fi)
OA (1) OA10107A (fi)
RU (1) RU94045872A (fi)
SI (1) SI9300228A (fi)
SK (1) SK129294A3 (fi)
WO (1) WO1993022333A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA883034B (en) * 1987-04-29 1989-03-29 Smithkline Beckman Corp Steroid 5-alpha-reductase inhibitors
AU627466B2 (en) * 1988-05-25 1992-08-27 Smithkline Beckman Corporation Aromatic steroid 5-alpha-reductase inhibitors
US4954446A (en) * 1988-05-25 1990-09-04 Smithkline Beecham Corporation Aromatic steroid 5-α-reductase inhibitors
CA2045866A1 (en) * 1990-06-28 1991-12-29 Gary H. Rasmusson 17-beta-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5 alpha-reductase inhibitors
EP0465123A3 (en) * 1990-06-28 1992-05-06 Merck & Co. Inc. New intermediates in the synthesis of 17beta-acyl-3-carboxy-androsta-3,5-dienes
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
ZA938B (en) * 1992-01-06 1994-06-16 Smithkline Beecham Corp Preparation of benzo esters and benzo acids
EP0567271B1 (en) * 1992-04-20 1997-07-02 Sankyo Company Limited Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
GB9224148D0 (en) * 1992-11-18 1993-01-06 Smithkline Beecham Corp Compounds

Also Published As

Publication number Publication date
HUT72467A (en) 1996-04-29
KR950701340A (ko) 1995-03-23
EP0638090A4 (en) 1995-10-04
BR9306419A (pt) 1998-09-15
JPH07506363A (ja) 1995-07-13
MA22886A1 (fr) 1993-12-31
US5618806A (en) 1997-04-08
AU4291993A (en) 1993-11-29
NZ252866A (en) 1996-09-25
FI945105A (fi) 1994-10-31
WO1993022333A1 (en) 1993-11-11
BG99145A (bg) 1995-08-28
HU9403117D0 (en) 1995-02-28
OA10107A (en) 1996-12-18
CZ266694A3 (en) 1995-07-12
RU94045872A (ru) 1996-08-27
FI945105A0 (fi) 1994-10-31
CA2134231A1 (en) 1993-11-11
CN1095071A (zh) 1994-11-16
SI9300228A (sl) 1993-12-31
SK129294A3 (en) 1995-07-11
NO944124L (no) 1994-10-31
EP0638090A1 (en) 1995-02-15
NO944124D0 (no) 1994-10-28

Similar Documents

Publication Publication Date Title
JPS6456694A (en) Steroid 5-alpha-reductase inhibitor
ZA883034B (en) Steroid 5-alpha-reductase inhibitors
PH30247A (en) Inhibitor of testosterone 5-alpha-reductase activity
AU4251993A (en) Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors
AP9300539A0 (en) Steroidal glycosides for treating hypercholest erolemia
EP0555845A3 (en) Steroid derivatives
IL105050A0 (en) Steroid derivatives
ZA934645B (en) 17-Alkylketone steroids useful as 5-alpha-reductase inhibitors
ZA939338B (en) New steroids
IL105527A0 (en) 17-beta-acyl-aromatic steroid 5-alpha-reductase inhibitors
HU9501844D0 (en) Difluoro-pentapeptide derivative anti-inflammatory agents
AU5118493A (en) Aromatase inhibitor
ZA931222B (en) TNF inhibitors
EP0650358A4 (en) 17-acyl-4-aza-steroid-3-one as 5-alpha-reductase inhibitors.
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors
GB9118480D0 (en) Steroid suphatase inhibitors
SG177994G (en) Steroid 5-alpha-reductase inhibitors
IL129131A0 (en) Inhibitors of testosterone 5- alpha-reductase activity
ZA932178B (en) Steroid derivatives
GB9118479D0 (en) Steroid sulphatase inhibitors
SI0724592T1 (en) 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
ZA939706B (en) New steroids
GB9224880D0 (en) Steroids
GB9207057D0 (en) Steroids
ZA935131B (en) 17-Spiromethylene steroids